Compare VANI & AMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VANI | AMTX |
|---|---|---|
| Founded | 1998 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 95.8M | 98.6M |
| IPO Year | 2014 | 2023 |
| Metric | VANI | AMTX |
|---|---|---|
| Price | $1.02 | $3.30 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | $4.00 | ★ $11.50 |
| AVG Volume (30 Days) | 178.5K | ★ 1.7M |
| Earning Date | 03-26-2026 | 03-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 32.98 |
| EPS | ★ N/A | N/A |
| Revenue | $4,000,000.00 | ★ $77,194,000.00 |
| Revenue This Year | N/A | $122.78 |
| Revenue Next Year | N/A | $40.84 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 174.60 |
| 52 Week Low | $0.91 | $1.22 |
| 52 Week High | $1.92 | $3.66 |
| Indicator | VANI | AMTX |
|---|---|---|
| Relative Strength Index (RSI) | 31.78 | 82.09 |
| Support Level | N/A | $2.17 |
| Resistance Level | $1.26 | $3.29 |
| Average True Range (ATR) | 0.06 | 0.34 |
| MACD | -0.01 | 0.12 |
| Stochastic Oscillator | 2.00 | 91.82 |
Vivani Medical Inc is a preclinical-stage biopharmaceutical company. The company develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division. The Biopharm Division includes activities from NPM and Vivani Medical Australia Pty Ltd, and the Neurostimulation Division includes activities from Cortigent and its subsidiary in Switzerland.
Aemetis Inc is an renewable fuel and biochemicals company focused on the production of renewable fuels and chemicals through the acquisition, development and commercialization of technologies that replace traditional petroleum-based products through the conversion of first-generation ethanol and biodiesel plants into biorefineries. It owns and operates an approximately 65 million gallon per year ethanol production facility located in Keyes, California. In addition to low carbon renewable fuel ethanol, the Keyes Plant produces Wet Distillers Grains, Distillers Corn Oil, and Condensed Distillers Solubles, all of which are sold to local dairies and feedlots as animal feed. It operates in the reportable geographic segments of North America and India.